InsidersTradesSigma
Explore the detailed record of transactions filed by Coleman Blaise, Chief Executive Officer. Insider active across 1 company, notably Endo International plc. In total, 2 disclosures have been published. History available since 5 March 2022. The latest transaction was disclosed on 29 March 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Blaise Coleman is the President and CEO of Endo International plc. He oversees the company's overall strategy and operations. With expertise in the pharmaceutical sector, he is committed to leading innovation and developing treatments that meet patient needs. His leadership is crucial for Endo's success.